GPT-Rosalind
ProprietaryLife Sciences
About
GPT-Rosalind is OpenAI's frontier reasoning model purpose-built for life sciences research, including biology, drug discovery, and translational medicine. Released April 16, 2026 via a restricted trusted access program (no public API). Outperforms GPT-5.4 on 6 of 11 LabBench 2 tasks (e.g., experimental design and literature retrieval) and on Bixbench for bioinformatics. Integrates with 50+ scientific tools via a Codex plugin. Access is limited to qualified research organizations through OpenAI's trusted access program. Parameters, context window, and pricing are not publicly disclosed.
Capabilities
VisionMultimodalReasoningFunction CallingTool UseStructured OutputsCode Execution
Specifications
FamilyGPT-Rosalind
Released2026-04-16
ArchitectureDecoder Only
Specializationlife-sciences
Created by
Cutting-edge research and development.
San Francisco, California, United States
Founded 2015
Website